Login

Olivia Lum is Group CEO and President of ground-breaking water treatment company Hyflux Ltd, one of Asia's largest in water and fluid solutions. 00:10:00

Share On Facebook Share On Twitter

Olivia Lum is Chairman/CEO at Hyflux Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Philippine Economy: Challenges and Opportunities| president , Ayala Corporation
00:00:00
Working on Infection Protection and Preventing the Global Expansion of Antimicrobial - Joe Todisco, CEO of CorMedix
00:10:00
Fuad Ajami on Iraq's Impact and Regional Dynamics
00:00:00
Diabetes diagnosis: What to expect -M. Regina Castro, M.D. Endocrinologist, Mayo Clinic
00:10:00
Our President and CEO highlights three key focus areas driving DXC Technology's unique value and business growth.|Raul Fernandez is president and chief executive officer of DXC Technology
00:10:00
Balancing Success: Insights from Todd Brand
00:10:00
Resolute Mining: CEO Terry Hulahan on Overcoming Challenges and Gold Production Growth in West Africa|Terry Holohan,Managing Director and Chief Executive Officer,Resolute Mining Ltd.
00:00:00
C4X Discovery on €3m Sanofi milestone payment and pipeline of other partnerships -Clive Dix BSc PhD HonFBPhS, Interim Executive Chairman & CEO, C4X Discovery Holding
00:10:00
"Integrating Sustainability for Future Growth: Insights from BBVA Asset Management's Strategic Sustainability Plan and ESG Framework"
00:00:00
Digitization and Decentralization of Clinical Trials - Dr. David Harmon, a Cardiology Fellow, both at Mayo Clinic
00:10:00
Fury Gold Mines: Advancing High-Grade Gold Projects in Canada
00:10:00
Dr. Andrew Tunks on Meteoric Resources' Cobalt Ventures: Unveiling Canada's Riches

© 2017 - Neuhu+